Cargando…

Rifampin-resistant/multidrug-resistant Tuberculosis in Alberta, Canada: Epidemiology and treatment outcomes in a low-incidence setting

Treatment of rifampin-monoresistant/multidrug-resistant Tuberculosis (RR/MDR-TB) requires long treatment courses, complicated by frequent adverse events and low success rates. Incidence of RR/MDR-TB in Canada is low and treatment practices are variable due to the infrequent experience and challenges...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edwards, Brett D., Edwards, Jenny, Cooper, Ryan, Kunimoto, Dennis, Somayaji, Ranjani, Fisher, Dina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886202/ https://www.ncbi.nlm.nih.gov/pubmed/33592031 http://dx.doi.org/10.1371/journal.pone.0246993

Ejemplares similares

Incidence, treatment, and outcomes of isoniazid mono-resistant Mycobacterium tuberculosis infections in Alberta, Canada from 2007-2017
por: Edwards, Brett D., et al.
Publicado: (2020)

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2020)

Transmission of Mycobacterium tuberculosis Beijing Strains, Alberta, Canada, 1991–2007
por: Langlois-Klassen, Deanne, et al.
Publicado: (2013)

Lymphocutaneous spread of Mycobacterium elephantis in an immunocompetent individual: A case report
por: Edwards, Brett D, et al.
Publicado: (2021)

Multicenter Study of the Accuracy of the BD MAX Multidrug-resistant Tuberculosis Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated With Resistance to Rifampin and Isoniazid
por: Shah, Maunank, et al.
Publicado: (2020)

Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family
por: Drobniewski, Francis, et al.
Publicado: (2002)

Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2022)

Mycobacterium tuberculosis and Rifampin Resistance, United Kingdom
por: Sam, I-Ching, et al.
Publicado: (2006)

Incidence and Outcomes of Endophthalmitis Associated Hospitalizations in Children Aged ≤ 20 Years: A Population-Based Cohort Study
por: Edwards, Brett, et al.
Publicado: (2017)

Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas
por: Pienaar, Elsje, et al.
Publicado: (2018)

Epidemiology of pertussis in Alberta, Canada 2004–2015
por: Liu, Xianfang C., et al.
Publicado: (2017)

Characterization of rifampin-resistant Staphylococcus aureus nasal carriage in patients receiving rifampin-containing regimens for tuberculosis
por: Huang, Yu-Tsung, et al.
Publicado: (2018)

A 10-Year Population Based Study of ‘Opt-Out’ HIV Testing of Tuberculosis Patients in Alberta, Canada: National Implications
por: Long, Richard, et al.
Publicado: (2014)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
por: Somoskovi, Akos, et al.
Publicado: (2001)

Mycobacterium tuberculosis Beijing Genotype Resistance to Transient Rifampin Exposure
por: den Hertog, Alice L., et al.
Publicado: (2014)

Oxycodone Resistance Due to Rifampin Use in an Osteosarcoma Patient with Tuberculosis
por: Sakamoto, Akio, et al.
Publicado: (2017)

rpoB Mutations and Effects on Rifampin Resistance in Mycobacterium tuberculosis
por: Li, Ma-chao, et al.
Publicado: (2021)

Rifampin-resistant Meningococcal Disease
por: Rainbow, Jean, et al.
Publicado: (2005)

Rifampin-resistant Neisseria meningitidis
por: Taha, Muhamed-Kheir, et al.
Publicado: (2006)

An Overlooked Cause of Rifampin Resistance
por: Agha, Yasmine Hussein, et al.
Publicado: (2020)

Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis
por: Loveday, Marian, et al.
Publicado: (2019)

Genotyping of rifampin-resistant Mycobacterium tuberculosis isolates from western Turkey
por: Cavusoglu, Cengiz, et al.
Publicado: (2004)

Molecular fingerprinting reveals familial transmission of rifampin-resistant tuberculosis in Kuwait
por: Mokaddas, Eiman, et al.
Publicado: (2005)

Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South Africa
por: Leavitt, Sarah V., et al.
Publicado: (2021)

Tuberculosis Variant with Rifampin Resistance Undetectable by Xpert MTB/RIF, Botswana
por: Modongo, Chawangwa, et al.
Publicado: (2023)

Is Universal Screening Necessary? Incidence of Tuberculosis among Tibetan Refugees Arriving in Calgary, Alberta
por: Lim, Rachel, et al.
Publicado: (2016)

The molecular epidemiology of incident methicillin-resistant Staphylococcus aureus cases among hospitalized patients in Alberta, Canada: a retrospective cohort study
por: Bush, Kathryn, et al.
Publicado: (2015)

Incidence of myeloproliferative neoplasms in Calgary, Alberta, Canada
por: Heppner, Jonathan, et al.
Publicado: (2019)

Factors associated with noncompletion of latent tuberculosis infection treatment in an inner-city population in Edmonton, Alberta
por: Malejczyk, Kathy, et al.
Publicado: (2014)

Trends in the Epidemiology and Treatment of Pediatric-Onset Multiple Sclerosis in Alberta, Canada
por: Yearwood, Camille, et al.
Publicado: (2023)

Nationwide Treatment Outcomes of Patients With Multidrug/Rifampin-Resistant Tuberculosis in Korea, 2011–2017: A Retrospective Cohort Study (Korean TB-POST)
por: Choi, Hongjo, et al.
Publicado: (2023)

Combined Rifampin and Sulbactam Therapy for Multidrug-Resistant Acinetobacter Baumannii Ventilator-Associated Pneumonia in Pediatric Patients
por: Chen, Jinlan, et al.
Publicado: (2018)

Repurposing 9-Aminoacridine as an Adjuvant Enhances the Antimicrobial Effects of Rifampin against Multidrug-Resistant Klebsiella pneumoniae
por: She, Pengfei, et al.
Publicado: (2023)

A Diagnostic Algorithm To Investigate Pyrazinamide and Ethambutol Resistance in Rifampin-Resistant Mycobacterium tuberculosis Isolates in a Low-Incidence Setting
por: Andres, Söenke, et al.
Publicado: (2019)

Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia
por: Ershova, Julia V., et al.
Publicado: (2015)

Incidence of chronic myeloid leukemia in Calgary, Alberta, Canada
por: Nguyen, Leonard Tu, et al.
Publicado: (2018)

Multidrug-resistant tuberculosis
por: Zager, Ellen M, et al.
Publicado: (2008)

Multidrug-resistant tuberculosis
por: Lemos, Antônio Carlos Moreira, et al.
Publicado: (2013)

Patient navigation programs in Alberta, Canada: an environmental scan
por: Tang, Karen L., et al.
Publicado: (2021)

Incidence of Multidrug-resistant Tuberculosis in Sindh, Pakistan
por: Khan, Rashid A, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1uu51v3lel3toiqou1slnqehev